Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

Chemoprevention, using drugs like finasteride and dutasteride, can help prevent prostate cancer.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Chronic use of 1 mg/day finasteride for hair loss may delay prostate cancer diagnosis by lowering PSA levels.

The FDA approved using Cialis with Proscar for better treatment options.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Men with better urinary symptoms have a lower risk of death.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Finasteride and dutasteride might lower melanoma risk.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Dutasteride effectively increases hair density in women with hair loss.

Combining tadalafil and finasteride improves their solubility and effectiveness.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Finasteride mildly affects semen but is reversible; dutasteride has stronger effects with incomplete recovery.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.

Nanostructured lipid carriers can improve androgenic alopecia treatment by reducing dutasteride dosage and maintaining its presence in hair follicles longer.

Discount pharmacies offer cheaper options for hair loss medications than traditional or direct-to-consumer pharmacies.

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.

Routine monitoring isn't needed for healthy patients on low-dose oral minoxidil, but is advised for those with kidney issues.